Perioperative Ostomy Self-Management Telehealth (Periop-OSMT) for Cancer Patients and Family Caregivers

Status: Active, not recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

This phase II trial studies how well Perioperative Ostomy Self-Management Telehealth (Periop-OSMT) provides patients and their caregivers information about ostomy and ostomy care. Periop-OSMT may help to understand patient preparedness to do ostomy self-care, confidence in doing ostomy self-care, knowledge of ostomy self-care, quality of life, mood, use of medical services, and financial burden.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• PATIENT: Scheduled to undergo a surgical procedure that includes the creation of an intestinal stoma (fecal or urinary).

• PATIENT: Able to read and understand English.

• PATIENT: Patients scheduled for temporary ostomy procedures

• SUPPORT PERSON/FCG: Family member/friend identified by the patient as the primary caregiver before and after surgery.

• SUPPORT PERSON/FCG: Able to read and understand English.

• Patients with all stages of disease are eligible for the study.

• The study is open to anyone regardless of gender or ethnicity. Efforts are made to extend the accrual to a representative population.

Locations
United States
Arizona
Banner University Medical Center - Tucson
Tucson
California
City of Hope Medical Center
Duarte
Pennsylvania
University of Pennsylvania/Abramson Cancer Center
Philadelphia
Time Frame
Start Date: January 23, 2020
Estimated Completion Date: December 18, 2022
Participants
Target number of participants: 6
Treatments
Experimental: Health service research (Periop-OSMT)
Patients and/or support persons/family caregivers complete Periop-OSMT session in-person or via telephone over 20-40 minutes before surgery and before hospital discharge and group telehealth session over 1.5-2 hours at weeks 1-3, 4, 5, 6, and 7 post discharge
Authors
Virginia Sun
Sponsors
Leads: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials